MID-SOUTH IMAGING & THERAPEUTICS, PA  620809858 -- BusinessCode: 621111 -- TN : GERMANTOWN
  [401(k)] MID-SOUTH IMAGING & THERAPEUTICS, PA PROFIT SHARING PLAN [620809858-002]
    2023  [codes: 2E2G2J2R3D]    https://efast2-filings-public.s3.amazonaws.com/prd/2024/9/23/20240923064557NAL0011096161001.pdf
        Participants: 89
        Available Investments:
           - JOHN HANCOCK USA
                 : 500 INDEX FUND  [010233346-000] P  $20,804
                 : AF THE GROWTH FUND OF AMERICA  [010233346-000] P  $207,946
                 : AMERICAN FUNDS EUROPAC GROWTH  [010233346-000] P  $119
                 : AMERICAN FUNDS NEW PERSPECTIVE  [010233346-000] P  $110,508
                 : DFA EMERGING MARKETS VALUE  [010233346-000] P  $118
                 : FIDELITY MID CAP INDEX FUND  [010233346-000] P  $40,620
                 : INVESCO SMALL CAP GROWTH  [010233346-000] P  $33,674
                 : JH LIFESTYLE BLEND AGGRESSIVE  [010233346-000] P  $85,832
                 : JH LIFESTYLE BLEND BALANCED  [010233346-000] P  $8,628
                 : JH LIFESTYLE BLEND GROWTH  [010233346-000] P  $232,335
                 : MFS VALUE FUND  [010233346-000] P  $164,063
                 : T. ROWE PRICE HEALTH SCI  [010233346-000] P  $116,998
                 : VANGUARD TARGET RET 2025  [010233346-000] P  $431,419
                 : VANGUARD TARGET RET 2030  [010233346-000] P  $1,473,707
                 : VANGUARD TARGET RET 2035  [010233346-000] P  $82,598
                 : VANGUARD TARGET RET 2040  [010233346-000] P  $237,810
                 : VANGUARD TARGET RET 2045  [010233346-000] P  $554,348
                 : VANGUARD TARGET RET 2050  [010233346-000] P  $1,040,660
                 : VANGUARD TARGET RET 2055  [010233346-000] P  $388,785
                 : VANGUARD TARGET RET 2060  [010233346-000] P  $270,178
                 : VANGUARD TARGET RET 2065  [010233346-000] P  $66,068
           = SUBTOTAL       $      5,567,218
           = OTHER          $     -5,567,218
